News
CILcare expands its Scientific Advisory Board to accelerate its research projects in synaptopathy, an early marker of age-related diseases
Montpellier, France, March 13 2023 – CILcare, a company specialized in the R&D of novel therapies for hearing disorders, has the immense pleasure of welcoming four renown researchers in the field of hearing to its Scientific Advisory Board (SAB): Keith Darrow,...
Join CILcare at ARO’s 2023 Midwinter Meeting
CILcare's team will be in Orlando, FL, to take part in ARO's Midwinter Meeting on February 11-15, 2023. The Association for Research in Otolaryngology (ARO) is an international hearing and vestibular research society that gathers universities, medical centers,...
Check out Celia Belline’s & Peter Markham’s interview in “This Week in Hearing”
In this interview with Hearing Health Matters, Celia and Peter recount their successful strategic collaboration, marking its fifth anniversary, and their recent award for their innovative preclinical auditory services in the third annual Hearing Technology Innovator...
Join CILcare at our booth at BioFIT 2022!
CILcare is glad to announce that Marie Peytavy-Izard, Marketing & Business Development Director, and Susanna Malmström, Alliances Director, will be holding a booth at the 2022 edition of BioFIT. Taking place in Strasbourg, France on November 29th and 30th, BioFIT...
CILcare-CBSET receive a Hearing Technology Innovator Award
LEXINGTON, Mass., USA, October 21st, 2022 — CILcare, a leading R&D services company dedicated to ear disorders, announced today that the company and its partner CBSET Inc., a not-for-profit translational research institute, have been recognized for their...
CILcare-CBSET nominated at the Hearing Technology Innovator Awards 2022
CILcare and its partner CBSET are proud to announce their nomination at the Hearing Technology Innovator Awards, which highlights their innovative auditory services that accelerate research and development of novel therapeutics. Lexington, MA - September 07th, 2022 -...
CILcare to present its advances on preclinical hearing loss models at IEB 2022
CILcare is glad to announce that its R&D team will be presenting its latest advances on preclinical hearing loss models at the 57th Inner Ear Biology workshop in Trieste, Italy, on September 10-13 2022. CILcare’s R&D team is looking forward to joining the next...
CILcare to give presentations on ototoxicity at ICT 2022
CILcare is pleased to announce that Marie-Pierre Pasdelou, Co-Founder & Chief Regulatory Officer, and Lise Byelyayeva, Business Developer, will be in Maastricht on September 18-21, 2022 to give presentations about CILcare's expertise on ototoxicity at the 16th...
